Capital World Investors 10x Genomics, Inc. Transaction History
Capital World Investors
- $586 Billion
- Q1 2024
A detailed history of Capital World Investors transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Capital World Investors holds 793,300 shares of TXG stock, worth $15.4 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
793,300
Previous 793,300
-0.0%
Holding current value
$15.4 Million
Previous $44.4 Million
32.94%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding TXG
# of Institutions
309Shares Held
92MCall Options Held
267KPut Options Held
62.1K-
Vanguard Group Inc Valley Forge, PA9.1MShares$177 Million0.01% of portfolio
-
Baillie Gifford & CO7.42MShares$144 Million0.22% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.28MShares$122 Million1.68% of portfolio
-
Black Rock Inc. New York, NY6.01MShares$117 Million0.01% of portfolio
-
Morgan Stanley New York, NY5.16MShares$100 Million0.02% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.85B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...